Clincosm LogoSign in Get a demo

metastatic breast cancer

Showing NaN - NaN of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Phoenix, Arizona
  • +36 more
Jan 27, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (LY3484356, Abemaciclib, Everolimus)

Recruiting
  • Breast Cancer
  • +3 more
  • Gilbert, Arizona
  • +76 more
Jan 27, 2023

Invasive Mammary Carcinoma, Metastatic Breast Cancer Trial in Nashville (Capecitabine, Endocrine-therapy, MammoPrint ® and

Not yet recruiting
  • Invasive Mammary Carcinoma
  • Metastatic Breast Cancer
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jan 11, 2023

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +4 more
  • West Hollywood, California
  • +101 more
Jan 16, 2023

Advanced Solid Tumor, Metastatic Breast Cancer Trial in United States (Abraxane)

Active, not recruiting
  • Advanced Solid Tumor
  • Metastatic Breast Cancer
  • Gilbert, Arizona
  • +19 more
Jan 13, 2023

Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

Recruiting
  • Metastatic Breast Cancer
  • Anchorage, Alaska
  • +58 more
Jan 6, 2023

Metastatic Breast Cancer Trial in United States (Sabizabulin, Exemestane monotherapy, exemestane plus everolimus, or selective

Not yet recruiting
  • Metastatic Breast Cancer
  • Sabizabulin
  • Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator
  • Anchorage, Alaska
  • +25 more
Dec 22, 2022

Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Tumor Trial in Worldwide (G1T48, Palbociclib)

Completed
  • Carcinoma, Ductal, Breast
  • +6 more
  • Beverly Hills, California
  • +14 more
Dec 14, 2022

Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

Not yet recruiting
  • Hormone Receptor-positive Breast Cancer
  • +2 more
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Oct 5, 2022

Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in United States (U3-1402)

Recruiting
  • Metastatic Breast Cancer
  • Locally Advanced Breast Cancer
  • Birmingham, Alabama
  • +9 more
Jul 18, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Metastatic Breast Cancer Trial in United States (Orteronel)

Completed
Has Results
  • Metastatic Breast Cancer
  • New Haven, Connecticut
  • +9 more
Jun 8, 2022

Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Boston, Nashville (Taselisib, Trastuzumab emtansine, Pertuzumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Recurrent Breast Cancer
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

Cancer Metastatic to the Liver, Hepatocellular Carcinoma, Metastatic Melanoma Trial in United States (PV-10 (10% rose bengal

Recruiting
  • Cancer Metastatic to the Liver
  • +9 more
  • PV-10 (10% rose bengal disodium)
  • San Diego, California
  • +4 more
Mar 22, 2022

Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant, Avelumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Miami, Florida
  • +21 more
Mar 18, 2022

Metastatic Breast Cancer, Hormone Receptor Positive Trial in United States (Palbociclib, Tamoxifen, Fulvestrant)

Completed
Has Results
  • Metastatic Breast Cancer
  • Hormone Receptor Positive
  • San Francisco, California
  • +8 more
Feb 16, 2022

Metastatic Breast Cancer, Breast Carcinoma Trial in United States (LEE-011, Fulvestrant, Placebo)

Active, not recruiting
  • Metastatic Breast Cancer
  • Breast Carcinoma
  • Birmingham, Alabama
  • +12 more
Feb 17, 2022

Advanced Solid Tumors, Metastatic Colon Cancer, Metastatic Breast Cancer Trial in United States (Fruquintinib (HMPL-013))

Recruiting
  • Advanced Solid Tumors
  • +6 more
  • Fruquintinib (HMPL-013)
  • Phoenix, Arizona
  • +8 more
Aug 30, 2021

Locally Recurrent Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (NKTR-102, Treatment of Physician's Choice (TPC))

Completed
Has Results
  • Locally Recurrent Breast Cancer
  • Metastatic Breast Cancer
  • NKTR-102
  • Treatment of Physician's Choice (TPC)
  • Flagstaff, Arizona
  • +152 more
May 6, 2021

Metastatic Breast Cancer Trial in Worldwide (Atezolizumab, Trastuzumab emtansine, Placebo)

Completed
Has Results
  • Metastatic Breast Cancer
  • Orange, California
  • +67 more
Jan 28, 2021

Metastatic Breast Cancer, Locally Recurrent Breast Cancer Trial in Worldwide (Eribulin, Balixafortide)

Unknown status
  • Metastatic Breast Cancer
  • Locally Recurrent Breast Cancer
  • Fresno, California
  • +87 more
Nov 26, 2020

Utilization of OncoCEE™ Platform to Evaluate Selected Biomarker

Completed
  • Metastatic Breast Cancer
    • Nashville, Tennessee
      Tennessee Oncology
    Sep 1, 2020

    Metastatic Breast Cancer Trial in San Francisco, Durham, Nashville (PLX3397, Eribulin)

    Completed
    Has Results
    • Metastatic Breast Cancer
    • San Francisco, California
    • +2 more
    Jul 2, 2020

    Breast Cancer, Metastatic Breast Cancer, MBC Trial in United States (Lucitanib)

    Terminated
    Has Results
    • Breast Cancer
    • +7 more
    • Sedona, Arizona
    • +32 more
    Jun 20, 2020

    Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

    Completed
    • Hematological Neoplasms
    • +19 more
    • Scottsdale, Arizona
    • +9 more
    May 11, 2020